Drugs affecting transmitter release from motor nerve terminals.
D000109:Acetylcholine / Q000378:metabolism*; D000110:Acetylcholinesterase; D000818:Animals; D001713:Biphenyl Compounds / Q000494:pharmacology*; D003014:Clostridium botulinum; D003864:Depression, Chemical; D003964:Diaphragm; D066298:In Vitro Techniques; D009046:Motor Neurons / Q000502:physiology*; D009157:Myasthenia Gravis / Q000503:physiopathology; D009469:Neuromuscular Junction / Q000187:drug effects / Q000201:enzymology / Q000502:physiology*; D010276:Parasympatholytics / Q000494:pharmacology*; D010791:Phrenic Nerve; D051381:Rats; D009435:Synaptic Transmission / Q000187:drug effects*; D014118:Toxins, Biological / Q000494:pharmacology
D001713:Biphenyl Compounds; D010276:Parasympatholytics; D014118:Toxins, Biological; D000110:Acetylcholinesterase; D000109:Acetylcholine